| 3.03 -0.05 (-1.62%) | 11-07 09:36 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.59 |
1-year : | 5.25 |
| Resists | First : | 3.93 |
Second : | 4.5 |
| Pivot price | 3.51 |
|||
| Supports | First : | 3.02 |
Second : | 2.51 |
| MAs | MA(5) : | 3.2 |
MA(20) : | 3.57 |
| MA(100) : | 3.69 |
MA(250) : | 3.15  |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 11.5 |
D(3) : | 9.6 |
| RSI | RSI(14): 36.9 |
|||
| 52-week | High : | 16.55 | Low : | 1.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SLSN ] has closed above bottom band by 8.1%. Bollinger Bands are 15.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.28 - 3.3 | 3.3 - 3.31 |
| Low: | 2.97 - 3 | 3 - 3.02 |
| Close: | 3.04 - 3.08 | 3.08 - 3.11 |
Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.
Thu, 21 Aug 2025
Earnings call transcript: Solesence Q2 2025 sees record revenue, stock dips - Investing.com
Sat, 26 Jul 2025
Solesence Is Growing A Lot, But The Stock Price Is Several Years In The Future - Seeking Alpha
Sun, 22 Jun 2025
Solesence: Flying Close To The Sun (Rating Downgrade) (NASDAQ:SLSN) - Seeking Alpha
Tue, 08 Apr 2025
SLSN Stock Price and Chart — NASDAQ:SLSN - TradingView
Mon, 07 Apr 2025
Solésence Announces Uplisting to Nasdaq - GlobeNewswire
Mon, 07 Apr 2025
Solésence moves to Nasdaq with new ticker SLSN - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 70 (M) |
| Shares Float | 18 (M) |
| Held by Insiders | 73.2 (%) |
| Held by Institutions | 5.6 (%) |
| Shares Short | 771 (K) |
| Shares Short P.Month | 892 (K) |
| EPS | 0.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.25 |
| Profit Margin | 8.1 % |
| Operating Margin | 9.3 % |
| Return on Assets (ttm) | 6.3 % |
| Return on Equity (ttm) | 34.7 % |
| Qtrly Rev. Growth | 56 % |
| Gross Profit (p.s.) | 0.25 |
| Sales Per Share | 0.91 |
| EBITDA (p.s.) | 0.08 |
| Qtrly Earnings Growth | 279.8 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | 38.5 |
| PEG Ratio | 0 |
| Price to Book value | 11.84 |
| Price to Sales | 3.36 |
| Price to Cash Flow | -146.68 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|